
Publication
Government of Alberta launches nuclear energy engagement
On August 25, 2025, the Government of Alberta publicly re-affirmed its interest in nuclear energy with the launch of its Nuclear Energy Engagement (the Engagement).
Canada | Publication | April 28, 2020 - 5 PM ET
As we previously advised, most deadlines in the period beginning March 16 and ending April 30, 2020, were extended to the next working day.
On April 27, the Canadian Intellectual Property Office (CIPO) extended this period until May 19, 2020.
Interestingly, on April 24 CIPO provided its current operational status in view of the ongoing COVID-19 pandemic and the deadline extension in a viewable presentation.
While CIPO remains open, there are many restrictions on activities conducted in person. Regional offices remain closed. However mail may be dropped off at offices in Gatineau and Ottawa.
The CIPO presentation also included a number of frequently asked questions (FAQs).
One interesting FAQ relates to electronic signatures. CIPO will follow the guidelines provided under section 3.3 of Annex F of the PCT Administrative Instructions.
CIPO will accept the following types of signatures:
Publication
On August 25, 2025, the Government of Alberta publicly re-affirmed its interest in nuclear energy with the launch of its Nuclear Energy Engagement (the Engagement).
Publication
Health Canada has proposed a major change to the regulation of biosimilar drugs that may accelerate biologic patent litigation in Canada. Following the lead of other jurisdictions, Health Canada has proposed that biosimilar manufacturers no longer be required to conduct phase 3 clinical trials to enter the Canadian market.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025